celanese corp. - CE

CE

Close Chg Chg %
58.27 -1.05 -1.80%

Closed Market

57.22

-1.05 (1.80%)

Volume: 2.55M

Last Updated:

Mar 28, 2025, 3:59 PM EDT

Company Overview: celanese corp. - CE

CE Key Data

Open

$58.27

Day Range

56.67 - 58.52

52 Week Range

45.94 - 172.10

Market Cap

$6.51B

Shares Outstanding

111.75M

Public Float

111.22M

Beta

1.22

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$13.91

Yield

360.04%

Dividend

$0.03

EX-DIVIDEND DATE

Feb 25, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

4.19M

 

CE Performance

1 Week
 
1.98%
 
1 Month
 
14.31%
 
3 Months
 
-15.31%
 
1 Year
 
-66.12%
 
5 Years
 
-18.30%
 

CE Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About celanese corp. - CE

Celanese Corp. engages in the provision of technology and specialty materials businesses. It operates through the following segments: Engineered Materials, Acetyl Chain, and Other Activities. The Engineered Materials segment includes the engineered materials business, food ingredients business and certain strategic affiliates. The Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers and ethylene vinyl acetate ("EVA") polymers businesses, based on similar products, production processes, classes of customers and selling and distribution practices as well as economic similarities over a normal business cycle. The Other Activities segment consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expenses associated with financing activities. The company was founded by Camille Dreyfus and Henri Dreyfus in 1918 and is headquartered in Irving, TX.

CE At a Glance

Celanese Corp.
222 West Las Colinas Boulevard
Irving, Texas 75039-5421
Phone 1-972-443-4000 Revenue 10.28B
Industry Chemicals: Specialty Net Income -1,522,000,000.00
Sector Process Industries Employees 12,163
Fiscal Year-end 12 / 2025
View SEC Filings

CE Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.736
Price to Book Ratio 1.462
Price to Cash Flow Ratio 7.829
Enterprise Value to EBITDA 10.558
Enterprise Value to Sales 1.944
Total Debt to Enterprise Value 0.648

CE Efficiency

Revenue/Employee 845,186.221
Income Per Employee -125,133.602
Receivables Turnover 6.369
Total Asset Turnover 0.416

CE Liquidity

Current Ratio 1.335
Quick Ratio 0.743
Cash Ratio 0.25

CE Profitability

Gross Margin 22.082
Operating Margin 10.798
Pretax Margin -9.689
Net Margin -14.805
Return on Assets -6.123
Return on Equity -24.686
Return on Total Capital -8.352
Return on Invested Capital -8.35

CE Capital Structure

Total Debt to Total Equity 250.28
Total Debt to Total Capital 71.451
Total Debt to Total Assets 56.665
Long-Term Debt to Equity 219.749
Long-Term Debt to Total Capital 62.735
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Celanese Corp. - CE

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
8.54B 9.67B 10.94B 10.28B
Sales Growth
+50.96% +13.31% +13.10% -6.03%
Cost of Goods Sold (COGS) incl D&A
5.88B 7.40B 8.49B 8.01B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
371.00M 461.00M 711.00M 783.00M
Depreciation
346.00M 399.00M 547.00M 624.00M
Amortization of Intangibles
25.00M 62.00M 164.00M 159.00M
COGS Growth
+34.35% +25.72% +14.85% -5.70%
Gross Income
2.65B 2.28B 2.45B 2.27B
Gross Income Growth
+107.99% -14.20% +7.42% -7.20%
Gross Profit Margin
+31.09% +23.54% +22.36% +22.08%
2021 2022 2023 2024 5-year trend
SG&A Expense
719.00M 936.00M 1.22B 1.16B
Research & Development
86.00M 112.00M 146.00M 130.00M
Other SG&A
633.00M 824.00M 1.07B 1.03B
SGA Growth
+29.32% +30.18% +30.45% -5.00%
Other Operating Expense
- - - -
-
Unusual Expense
7.00M (31.00M) 73.00M 1.68B
EBIT after Unusual Expense
1.93B 1.37B 1.15B (568.00M)
Non Operating Income/Expense
420.00M 454.00M 751.00M 241.00M
Non-Operating Interest Income
8.00M 69.00M 39.00M 33.00M
Equity in Earnings of Affiliates
146.00M 220.00M 102.00M 196.00M
Interest Expense
100.00M 405.00M 720.00M 669.00M
Interest Expense Growth
-8.26% +305.00% +77.78% -7.08%
Gross Interest Expense
112.00M 423.00M 757.00M 699.00M
Interest Capitalized
12.00M 18.00M 37.00M 30.00M
Pretax Income
2.25B 1.42B 1.18B (996.00M)
Pretax Income Growth
-0.13% -36.79% -16.75% -184.19%
Pretax Margin
+26.33% +14.69% +10.81% -9.69%
Income Tax
330.00M (489.00M) (790.00M) 510.00M
Income Tax - Current - Domestic
- 54.00M 8.00M 79.00M
Income Tax - Current - Foreign
323.00M 306.00M 162.00M 239.00M
Income Tax - Deferred - Domestic
(16.00M) (261.00M) (178.00M) (87.00M)
Income Tax - Deferred - Foreign
23.00M (588.00M) (782.00M) 279.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
146.00M 220.00M 102.00M 196.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.92B 1.91B 1.97B (1.51B)
Minority Interest Expense
6.00M 8.00M 4.00M 8.00M
Net Income
1.91B 1.90B 1.97B (1.51B)
Net Income Growth
-4.26% -0.52% +3.52% -176.89%
Net Margin Growth
+22.40% +19.66% +18.00% -14.73%
Extraordinaries & Discontinued Operations
(22.00M) (8.00M) (9.00M) (8.00M)
Discontinued Operations
(22.00M) (8.00M) (9.00M) (8.00M)
Net Income After Extraordinaries
1.89B 1.89B 1.96B (1.52B)
Preferred Dividends
- - - -
-
Net Income Available to Common
1.89B 1.89B 1.96B (1.52B)
EPS (Basic)
16.9927 17.4755 18.0066 -13.9283
EPS (Basic) Growth
+0.86% +2.84% +3.04% -177.35%
Basic Shares Outstanding
111.22M 108.38M 108.85M 109.27M
EPS (Diluted)
16.8623 17.3387 17.9192 -13.9283
EPS (Diluted) Growth
+0.65% +2.83% +3.35% -177.73%
Diluted Shares Outstanding
112.08M 109.24M 109.38M 109.27M
EBITDA
2.31B 1.80B 1.94B 1.89B
EBITDA Growth
+115.72% -21.86% +7.44% -2.22%
EBITDA Margin
+27.01% +18.63% +17.70% +18.41%

Snapshot

Average Recommendation HOLD Average Target Price 61.35
Number of Ratings 22 Current Quarters Estimate 0.396
FY Report Date 03 / 2025 Current Year's Estimate 5.525
Last Quarter’s Earnings 1.45 Median PE on CY Estimate N/A
Year Ago Earnings 8.37 Next Fiscal Year Estimate 7.693
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 19 20 19
Mean Estimate 0.40 1.46 5.52 7.69
High Estimates 0.58 1.82 6.65 10.00
Low Estimate 0.25 1.25 4.00 5.50
Coefficient of Variance 20.23 8.98 12.52 12.50

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 5 5
OVERWEIGHT 1 1 1
HOLD 11 12 11
UNDERWEIGHT 1 1 2
SELL 3 4 4
MEAN Hold Hold Hold

Insider Actions for Celanese Corp. - CE

Date Name Shares Transaction Value
Mar 14, 2025 Edward G. Galante Director 6,790 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Jay V. Ihlenfeld Director 10,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Deborah J. Kissire Director 4,796 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Kim K. W. Rucker Director 8,382 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Ganesh Moorthy Director 3,000 Open market or private purchase of non-derivative security Non-derivative transaction at $53.29 per share 159,870.00
Mar 14, 2025 Kathryn M. Hill Director 2,943 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2025 Scott McDougald Sutton Director 15,000 Open market or private purchase of non-derivative security Non-derivative transaction at $54.65 per share 819,750.00
Mar 11, 2025 Mark Christopher Murray SVP - Acetyls 13,989 Open market or private purchase of non-derivative security Non-derivative transaction at $54.45 per share 761,701.05
Mar 3, 2025 Ashley B. Duffie SVP & GC 17,124 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Aaron M. McGilvray Chief Accounting Officer 2,114 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Scott A. Richardson CEO & President; Director 95,137 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Todd Elliott SVP, EM 21,564 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Chuck B. Kyrish SVP & CFO 25,369 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Mark Christopher Murray SVP - Acetyls 11,636 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.13 per share 804,396.68
Feb 20, 2025 Aaron M. McGilvray Chief Accounting Officer 5,944 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.13 per share 410,908.72
Feb 20, 2025 Ashley B. Duffie SVP & GC 13,835 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.13 per share 956,413.55
Feb 20, 2025 Scott A. Richardson CEO & President; Director 66,649 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.13 per share 4,607,445.37
Feb 20, 2025 Chuck B. Kyrish SVP & CFO 5,914 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.13 per share 408,834.82
May 15, 2024 Michael König Director 2,203 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.07 per share 350,431.21
May 15, 2024 William M. Brown Director 103 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00

Celanese Corp. in the News